QGS has joined forces with Australian research institutes to complete cell and animal experiments on QV0's cancer cell inhibition and tumor efficacy. The results, which have been published in international oncology journals, show that the use of QV0 greatly inhibited tumor growth without any negative effects on normal cells or animal health. This success has attracted the attention of many organizations specializing in cancer treatment, and the research institute has received full support from Australian government agencies. Phase I human clinical trials are being conducted independently at research and development facilities and hospitals in Sydney, and are fully funded by the relevant Australian agencies.